DGAP-News: IBS AG excellence, collaboration, manufacturing: Control Agreement Entered in the IBS AG Commercial Register
(firmenpresse) - DGAP-News: IBS AG excellence, collaboration, manufacturing / Key
word(s): Contract
IBS AG excellence, collaboration, manufacturing: Control Agreement
Entered in the IBS AG Commercial Register
17.12.2012 / 18:34
---------------------------------------------------------------------
IBS AG: Control Agreement Entered in the IBS AG Commercial Register
- Control agreement between Siemens Beteiligungen Inland GmbH as
controlling company and IBS AG as a controlled company effective upon
entry in the IBS AG commercial register
- The control agreement and associated opportunities and perspectives
Hoehr-Grenzhausen, 17th December 2012 - The control agreement between
Siemens Beteiligungen Inland GmbH as controlling company and IBS AG (ISIN
DE0006228406) as a controlled company became effective as of 17th December
2012, upon entry in the IBS AG commercial register. IBS AG shareholders
approved the control agreement, dated 10th/11th October 2012, at the
Extraordinary General Meeting held on 29th November 2012. The General
Assembly of Siemens Beteiligungen Inland GmbH gave its approval of the
control agreement on 10th October 2012.
The object of the control agreement is, inter alia, a cash settlement in
accordance with§305 of the German Stock Corporation Act (AktG) to the sum
of 6.90 EUR per IBS AG Share and an adjustment payment in accordance with§304 of the German Stock Corporation Act (AktG) to the gross sum of 0.26 EUR
(net value after corporate tax and solidarity contribution: 0.23 EUR) for
each full financial year per IBS AG Share. Siemens Beteiligungen Inland
GmbH is also obligated to compensate any losses incurred by IBS AG in
accordance with the provisions of§302 of the German Stock Corporation Act
(AktG) in the applicable version. The obligation to compensate losses
initially applies to the entire financial year in which the control
agreement becomes effective. In its auditing report, the court-appointed
contract auditor, Warth + Klein Grant Thornton AG
Wirtschaftspruefungsgesellschaft, Dusseldorf, considers the cash settlement
in accordance with§305 of the German Stock Corporation Act (AktG) and the
adjustment payment in accordance with§304 of the German Stock Corporation
Act (AktG) to be adequate.
With the conclusion of the control agreement, IBS AG anticipates being able
to react to market developments both quicker and more flexibly, whilst also
realising a whole range of synergies in the areas of development,
technology and sales. Our larger customers, in particular, are increasingly
opting for larger partners for their production-critical business
relationships, in order to achieve greater investment security.
A whole host of mutual synergies with Siemens are expected, inter alia, in
the area of sales and marketing. The thus far different target markets,
solutions portfolios and customer structures hold the potential to
achieving a significantly greater range, along with an associated increase
in turnover and revenues. This will enable the development of new markets,
not only geographically but also in terms of strategic and technological
target groups. Close co-operation between the common sales channels will
also have a positive effect here. The incorporation of IBS products in the
Siemens Group market presence will offer further opportunities in the
sharing and joint creation of websites, brochures, media, design resources
and campaigns.
Synergies will continue to arise from the bundling of research and
development activities In future, IBS Group products will be not only be
harmonised in the Siemens environment as integrated solutions for
production management (MES - Manufacturing Execution Systems) and PLM
(Product Lifecycle Management), but also used as before, on a stand-alone
basis in the usual environment. Technologically speaking, developers and
engineers alike will benefit from mutual resource access.
Last but not least, the Siemens Group will offer further benefits in the
areas of employee recruitment and loyalty. Favourable purchasing conditions
and framework agreements with suppliers and partners will also ensue.
About IBS AG:
IBS AG is a leading supplier of cross-company standard software systems and
consulting services for industrial quality, production, traceability and
compliance management. In keeping with the corporate philosophy 'The
Productivity Advantage', IBS AG's Best Practice solutions contribute to a
sustainable boost in corporate productivity. IBS customers receive the
support of a team of experienced consultants and specialists throughout
each phase of the project and beyond. IBS AG, founded in 1982, today
employs 229 personnel in Europe, China and the USA.
The Company is listed in the Prime Standard of the German Stock Exchange in
Frankfurt/Main (ISIN DE0006228406).
IBS AG software solutions amount to over 4,000 installations worldwide and
can be found at companies such as Audi, Beam Global, BMW, BorgWarner,
BOSCH, Caterpillar, Daimler, Electronic Networks, FCI Automotive, Kimberly
Clark, Liebherr, Magna Automotive, KautexTextron, Parker Hannifin, Procter&Gamble, Rock Tenn, Porsche, Siemens, SMA Solar Technology, ThyssenKrupp
and W.L. Gore.
Contact
Investor Relations IBS AG
c/o MLC Finance GmbH
Mussener Weg 7
95213 Muenchberg
Mr. Michael Lang
Tel.: + 49 (0) 9251 44088 30
Fax: + 49 (0) 9251 44088 31
e-mail: investorrelations(at)ibs-ag.de
Mr. Stefan Stroeder
Tel. +49 (0) 2624 9180 475
Fax +49 (0) 9251 440 88 31
e-mail: investorrelations(at)ibs-ag.de
End of Corporate News
---------------------------------------------------------------------
17.12.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: IBS AG excellence, collaboration, manufacturing
Rathausstrasse 56
56203 Höhr-Grenzhausen
Germany
Phone: +49 (0)9251 44 088-30
Fax: +49 (0)9251 44 088-31
E-mail: investorrelations(at)ibs-ag.de
Internet: www.ibs-ag.de
ISIN: DE0006228406
WKN: 622840
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
197240 17.12.2012
Themen in dieser Pressemitteilung:
ibs-ag-excellence
collaboration
manufacturing-control-agreement-entered-in-the-ibs-ag-commercial-register
Unternehmensinformation / Kurzprofil:




">

Datum: 17.12.2012 - 18:34 Uhr
Sprache: Deutsch
News-ID 213452
Anzahl Zeichen: 8395
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 334 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: IBS AG excellence, collaboration, manufacturing: Control Agreement Entered in the IBS AG Commercial Register"
steht unter der journalistisch-redaktionellen Verantwortung von
IBS AG excellence, collaboration, manufacturing (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).